Advance care planning after lung transplantation: a case of missed opportunities.
After lung transplantation, recipients are regularly evaluated by the transplant team and often require multiple hospitalizations. The primary focus of care during this time is on detecting and treating complications and may not necessarily include advance care planning discussions. This focus may leave clinicians unaware of the recipient's treatment preferences and place a burden on families trying to decide whether to undergo or forgo life-sustaining treatment when the recipient's medical condition deteriorates. We report the case of a woman with bronchiolitis obliterans who was admitted to the transplant center 37 times and died in the intensive care unit. Although progressive deterioration of her medical condition was well documented, her medical records revealed no evidence of advance care planning discussions with the patient and family. Incorporating timely advance care planning and integrating palliative care in the ongoing posttransplant clinical management may benefit patients, families, and clinicians as recipients approach the final stage of their illness.
Song
Mi-Kyung
MK
Department of Acute & Tertiary Care, School of Nursing, University of Pittsburgh, PA, USA.
De Vito Dabbs
Annette J
AJ
D000328:Adult; D032722:Advance Care Planning / Q000458:organization & administration*; D001989:Bronchiolitis Obliterans / Q000209:etiology*; D015897:Comorbidity; D003422:Critical Care; D003550:Cystic Fibrosis / Q000601:surgery; D018450:Disease Progression; D004282:Documentation; D005260:Female; D006084:Graft Rejection; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D007902:Length of Stay / Q000706:statistics & numerical data; D016040:Lung Transplantation / Q000009:adverse effects* / Q000276:immunology; D018447:Medical Futility; D008499:Medical Records; D009737:Nursing Records; D010347:Patient Care Planning; D010359:Patient Readmission / Q000706:statistics & numerical data; D013997:Time Factors; D028761:Withholding Treatment
D007166:Immunosuppressive Agents